Sigma Planning Corp’s Ascendis Pharma A/S ASND Stock Holding History

Sigma Planning Corp’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$611K	Sell	2,290 -5,007	-69%	-$1.17M	0.02%	826
2026 Q1	$1.67M	Buy	7,297 +2,513	+53%	+$563K	0.05%	387
2025 Q4	$1.02M	Sell	4,784 -2,820	-37%	-$582K	0.03%	525
2025 Q3	$1.51M	Buy	7,604 +3,500	+85%	+$653K	0.04%	398
2025 Q2	$708K	Buy	4,104 +2,589	+171%	+$422K	0.02%	639
2025 Q1	$236K	Buy	+1,515	New	+$216K	0.01%	1052

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sigma Planning Corp's ASND Position: Q2 2026 in Review

Sigma Planning Corp reduced its Ascendis Pharma A/S (ASND) stake by 69% in Q2 2026, selling an estimated $1.17M and leaving 2,290 shares worth $611K. The position accounts for 0.02% of the portfolio, ranked #826.

Sigma Planning Corp first reported a position in ASND in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.67M in Q1 2026. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Sigma Planning Corp held 2,290 shares of Ascendis Pharma A/S worth $611K as of Q2 2026.
Sigma Planning Corp sold 5,007 Ascendis Pharma A/S shares in Q2 2026, an estimated $1.17M.
Ascendis Pharma A/S made up 0.02% of Sigma Planning Corp's portfolio in Q2 2026, its #826 holding.
Sigma Planning Corp first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 6 quarters since.
Sigma Planning Corp's Ascendis Pharma A/S position peaked at $1.67M in Q1 2026.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Sigma Planning Corp's 13F filing for Q2 2026, filed 7 Aug 2026.